Aseptic Meningitis as a Manifestation of NPSLE

Epidemiology and Clinical Context

• Aseptic meningitis is classified as a rare NPSLE manifestation with a cumulative incidence of less than 1%, making it one of the least common neuropsychiatric presentations of SLE 1, 2
• NPSLE manifestations commonly occur within the first year after SLE diagnosis (50-60% of cases) and frequently present alongside generalized disease activity (40-50% of cases) 3, 1

Critical Diagnostic Approach

• The EULAR guidelines emphasize that lumbar puncture with CSF analysis and MRI should be performed to exclude non-SLE causes, especially infection 4
• Lumbar puncture with comprehensive CSF analysis, including cell count, protein, glucose, Gram stain, culture, and PCR for viruses, is essential for diagnosis 4, 2
• MRI of the brain using conventional sequences, diffusion-weighted imaging, and gadolinium-enhanced T1 sequences is recommended 2

Important Differential Considerations

• Before diagnosing lupus-related aseptic meningitis, infectious meningitis (bacterial, viral, fungal) must be excluded, as it is the priority 4, 2
• Sinus thrombosis, particularly in patients with antiphospholipid antibodies, and cerebral or subarachnoid hemorrhage must also be considered 4, 5

Treatment When Confirmed as NPSLE

• Glucocorticoids and immunosuppressive therapy are indicated for aseptic meningitis when it reflects an immune/inflammatory process, following exclusion of non-SLE-related causes 2
• High-dose glucocorticoids are the first-line treatment, and immunosuppressive agents may be added in severe cases 4
• The combination of glucocorticoids and immunosuppressive agents typically shows good response rates (60-80%) in inflammatory NPSLE manifestations 6

Critical Pitfall to Avoid

• The most dangerous error is attributing meningitis to lupus without adequately excluding infection, especially in immunosuppressed patients, as emphasized by the EULAR guidelines with a 9.6 agreement score 4